Clonal CD4 T-Cells in Lung Transplant Recipients
肺移植受者中的克隆性 CD4 T 细胞
基本信息
- 批准号:7568904
- 负责人:
- 金额:$ 35.58万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2006
- 资助国家:美国
- 起止时间:2006-02-01 至 2011-01-31
- 项目状态:已结题
- 来源:
- 关键词:Abnormal CellAdoptive TransferAllogenicAllograftingAnimal ModelAntigensAttentionAutologousAvidityBiological AssayBiological MarkersBronchiolitisCD28 geneCD4 Positive T LymphocytesCell DeathCell TherapyCell TransplantsCell physiologyCellsCharacteristicsChimera organismChronicClinicalClonal ExpansionClonalityComplexComplicationControl AnimalCross-Sectional StudiesDevelopmentDiagnosisDiagnosticDiseaseDown-RegulationEarly DiagnosisEpithelial CellsEventExhibitsFlow CytometryGene ExpressionGenerationsHumanImmuneImmune System DiseasesImmune responseImmunobiologyImmunodeficient MouseImplantInflammatoryInjuryInterventionInvestigationLeadLungLung TransplantationLymphocyteMeasuresMediatingMediator of activation proteinModalityModelingMusNOD/SCID mouseNatural Killer CellsPathogenesisPathogenicityPeripheral Blood Mononuclear CellPhenotypePlayPopulationPreventiveProliferatingRNase protection assayRefractoryRoleSensitivity and SpecificitySpecificityT-LymphocyteTestingTherapeuticTimeTransplant RecipientsTreatment ProtocolsUpper armXenograft procedureairway remodelingassay developmentbaseclinically significantcohortcytokinein vivoinnovationinsightlung allograftnovelpreventprotein expressionreceptorresponse
项目摘要
Obliterative bronchiolitis (OB) is a frequent and often devastating complication of lung transplantation that is
usually refractory to treatments. Although the pathogenesis of OB is clearly immune-mediated, details of
these mechanisms remain uncertain. We have recently shown that CD4 T-cells of transplant recipients with
OB seem to be invariably characterized by extreme oligclonal proliferations and CD28 downregulation, and
these abormalities are largely absent amoung recipients without rejection. We believe these abnormal T-
cells play a critical role in development of OB by either causing direct injuries to the allograft, or by
orchestrating an inflammatory cascade with elaborations of chemotactic and activating mediators. The
projects of this proposal will conduct serial assays of a lung transplant recipient cohort, to establish whether
findings of CD4 clonal expansions and CD28 downregulation are useful for diagnosis or prediction of OB.
Other studies will characterize these unusual cells and establish their antigen specificities, and delineate
their proliferative and cytolytic functions. We have also developed a novel human-murine chimeric model
using xenografts of human airways in immunodeficient mice that will enable in vivo assays of immune effects
and functions after adoptive transfer of allogeneic (to the airway) human T-cells. We anticipate the focus of
these studies on the early events of the immune responses to allografts will result in important new findings
that provide insights into the immunopathogenesis of OB. Furthermore, findings here may also open
avenues for development of innovative, diagnostic and therapeutic modalities, including earlier and more
efficacious interventions to prevent or treat OB.
闭孔性支气管炎(OB)是一种频繁且经常毁灭性的肺移植并发症,是
通常对治疗难治性。尽管OB的发病机理显然是免疫介导的,但
这些机制仍然不确定。我们最近表明,具有移植受者的CD4 T细胞
OB似乎总是以极端的寡头增生和CD28下调为特征,并且
这些劣势在很大程度上是没有拒绝的接受者。我们相信这些异常t-
细胞通过对同种异体移植造成直接伤害或通过
用趋化和激活介体的阐述来策划炎症性级联。这
该提案的项目将进行肺移植接受者队列的串行测定,以确定是否是否
CD4克隆扩张和CD28下调的发现可用于诊断或预测OB。
其他研究将表征这些异常细胞并建立其抗原特异性,并描述
它们的增殖和细胞溶解功能。我们还开发了一种新型的人类熔融嵌合模型
在免疫缺陷的小鼠中使用人类气道的异种移植物,这将使体内实现免疫作用。
和同种异体转移(气道)人类T细胞后的功能。我们预计将重点
这些关于对同种异体移植物免疫反应的早期事件的研究将导致重要的新发现
这提供了对OB的免疫发病发生的见解。此外,这里的发现也可能打开
开发创新,诊断和治疗方式的途径,包括早期以及更多
有效的干预措施以防止或治疗OB。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
STEVEN R DUNCAN其他文献
STEVEN R DUNCAN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('STEVEN R DUNCAN', 18)}}的其他基金
Phase II Clinical Trial of the Safety and Efficacy if a NOX1/4 Inhibitor in IPF
NOX1/4抑制剂治疗IPF的安全性和有效性的II期临床试验
- 批准号:
10218251 - 财政年份:2013
- 资助金额:
$ 35.58万 - 项目类别:
Impact of CCR5 inhibition on Sarcoid Immunophenotypes
CCR5 抑制对结节病免疫表型的影响
- 批准号:
8658464 - 财政年份:2012
- 资助金额:
$ 35.58万 - 项目类别:
Impact of CCR5 inhibition on Sarcoid Immunophenotypes
CCR5 抑制对结节病免疫表型的影响
- 批准号:
8265084 - 财政年份:2012
- 资助金额:
$ 35.58万 - 项目类别:
Impact of CCR5 inhibition on Sarcoid Immunophenotypes
CCR5 抑制对结节病免疫表型的影响
- 批准号:
8474836 - 财政年份:2012
- 资助金额:
$ 35.58万 - 项目类别:
The Role of Humoral Autoimmunity in Idiopathic Pulmonary Fibrosis
体液自身免疫在特发性肺纤维化中的作用
- 批准号:
8073301 - 财政年份:2011
- 资助金额:
$ 35.58万 - 项目类别:
The Role of Humoral Autoimmunity in Idiopathic Pulmonary Fibrosis
体液自身免疫在特发性肺纤维化中的作用
- 批准号:
8259733 - 财政年份:2011
- 资助金额:
$ 35.58万 - 项目类别:
Clonal CD4 T-Cells in Lung Transplant Recipients
肺移植受者中的克隆性 CD4 T 细胞
- 批准号:
7031202 - 财政年份:2006
- 资助金额:
$ 35.58万 - 项目类别:
相似海外基金
Randomized study of low versus moderate dose busulfan in transplant for severe combined immunodeficiency
低剂量与中剂量白消安治疗严重联合免疫缺陷移植的随机研究
- 批准号:
10197472 - 财政年份:2017
- 资助金额:
$ 35.58万 - 项目类别:
Randomized study of low versus moderate dose busulfan in transplant for severe combined immunodeficiency
低剂量与中剂量白消安治疗严重联合免疫缺陷移植的随机研究
- 批准号:
10474806 - 财政年份:2017
- 资助金额:
$ 35.58万 - 项目类别:
Randomized study of low versus moderate dose busulfan in transplant for severe combined immunodeficiency
低剂量与中剂量白消安治疗严重联合免疫缺陷移植的随机研究
- 批准号:
10683141 - 财政年份:2017
- 资助金额:
$ 35.58万 - 项目类别:
Randomized study of low versus moderate dose busulfan in transplant for severe combined immunodeficiency
低剂量与中剂量白消安治疗严重联合免疫缺陷移植的随机研究
- 批准号:
10474994 - 财政年份:2017
- 资助金额:
$ 35.58万 - 项目类别:
Randomized study of low versus moderate dose busulfan in transplant for severe combined immunodeficiency
低剂量与中剂量白消安治疗严重联合免疫缺陷移植的随机研究
- 批准号:
9755344 - 财政年份:2017
- 资助金额:
$ 35.58万 - 项目类别: